Lentiviral-mediated delivery of Bcl-2 or GDNF protects against excitotoxicity in the rat hippocampus

Molecular Therapy

Volumn 11, Issue 1, 2005, Pages 89-95

  Wong, Liang Fong ^a   Scott Ralph, G ^a   Walmsley, Lucy E ^a   Bienemann, Alison S ^b   Parham, Stephen ^a   Kingsman, Susan M ^a   Uney, James B ^b   Mazarakis, Nicholas D ^a  

^a OXFORD BIOMEDICA UK LTD   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMIC ACID; LENTIVIRUS VECTOR; N METHYL DEXTRO ASPARTIC ACID; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; CELL CULTURE; CELL LOSS; CELL PROTECTION; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; EQUINE INFECTIOUS ANEMIA VIRUS VECTOR; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; HIPPOCAMPUS; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; NERVE CELL; NEUROPROTECTION; NONHUMAN; RAT; RAT STRAIN; TARGET ORGAN; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; CELL LINE; GENETIC VECTORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HIPPOCAMPUS; HUMANS; LENTIVIRUS; N-METHYLASPARTATE; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; TISSUE CULTURE TECHNIQUES;

EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; RATTUS NORVEGICUS;

EID: 10944242029     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2004.08.026     Document Type: Article

References (41)

1. W.A. Pulsinelli J.B. Brierley F. Plum Temporal profile of neuronal damage in a model of transient forebrain ischemia Ann. Neurol. 11 1982 491-498
2. D.W. Choi S.M. Rothman The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death Annu. Rev. Neurosci. 13 1990 171-182
3. D.W. Choi Calcium: Still center-stage in hypoxic-ischemic neuronal death Trends Neurosci. 18 1995 58-60
4. H. Kitagawa Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents ischemic brain injury after transient middle cerebral artery occlusion in rats J. Cereb. Blood Flow Metab. 19 1999 1336-1344
5. D.M. Hermann et al. Adenovirus-mediated glial cell line-derived neurotrophic factor (GDNF) expression protects against subsequent cortical cold injury in rats Neurobiol. Dis. 8 2001 964-973
6. D.G. Xu et al. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus Nat. Med. 3 1997 997-1004
7. G.Y. Yang Y.J. Zhao B.L. Davidson A.L. Betz Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury Brain Res. 751 1997 181-188
8. G.Y. Yang et al. Attenuation of ischemia-induced mouse brain injury by SAG, a redox-inducible antioxidant protein J. Cereb. Blood Flow Metab. 21 2001 722-733
9. K. Shimazaki et al. Adeno-associated virus vector-mediated bcl-2 gene transfer into post-ischemic gerbil brain in vivo: Prospects for gene therapy of ischemia-induced neuronal death Gene Ther. 7 2000 1244-1249
10. T.H. Tsai et al. Recombinant adeno-associated virus vector expressing glial cell line-derived neurotrophic factor reduces ischemia-induced damage Exp. Neurol. 166 2000 266-275
11. M.S. Lawrence et al. Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo J. Neurosci. 16 1996 486-496
12. M.D. Linnik P. Zahos M.D. Geschwind H.J. Federoff Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia Stroke 26 1885 1670-1674
13. M.A. Yenari et al. Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy Ann. Neurol. 44 1998 584-591
14. C.R. Ozawa et al. Neuroprotective potential of a viral vector system induced by a neurological insult Proc. Natl. Acad. Sci. USA 97 2000 9270-9275
15. N.D. Mazarakis et al. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery Hum. Mol. Genet. 10 2001 2109-2121
16. M. Azzouz et al. Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic l-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson's disease J. Neurosci. 22 2002 10302-10312
17. A.S. Bienemann et al. Long-term replacement of a mutated nonfunctional CNS gene: Reversal of hypothalamic diabetes insipidus using an EIAV-based lentiviral vector expressing arginine vasopressin Mol. Ther. 7 2003 588-596
18. D.T. Monaghan V.R. Holets D.W. Toy C.W. Cotman Anatomical distributions of four pharmacologically distinct 3H-l-glutamate binding sites Nature 306 1983 176-179
19. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55-63
20. L.C. Schmued C. Albertson W. Slikker Jr. Fluoro-Jade: A novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration Brain Res. 751 1997 37-46
21. L.C. Schmued K.J. Hopkins Fluoro-Jade B: A high affinity fluorescent marker for the localization of neuronal degeneration Brain Res. 874 2000 123-130
22. K. Shimazaki A. Ishida N. Kawai Increase in bcl-2 oncoprotein and the tolerance to ischemia-induced neuronal death in the gerbil hippocampus Neurosci. Res. 20 1994 95-99
23. J. Nilsen R.D. Brinton Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression Proc. Natl. Acad. Sci. USA 100 2003 2842-2847
24. A.B. MacDermott et al. NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones Nature 321 1986 519-522
25. D.M. Hockenbery et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis Cell 75 1993 241-251
26. D.J. Kane et al. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species Science 262 1993 1274-1277
27. A. Dumuis et al. NMDA receptors activate the arachidonic acid cascade system in striatal neurons Nature 336 1988 68-70
28. M. Lafon-Cazal S. Pietri M. Culcasi J. Bockaert NMDA-dependent superoxide production and neurotoxicity Nature 364 1993 535-537
29. C. Bonde et al. GDNF and neublastin protect against NMDA-induced excitotoxicity in hippocampal slice cultures Neuroreport 11 2000 4069-4073
30. Y. Wang et al. Protective effects of glial cell line-derived neurotrophic factor in ischemic brain injury Ann. N.Y. Acad. Sci. 962 2002 423-437
31. A. Sarabi B.J. Hoffer L. Olson M. Morales GFR alpha-1 is expressed in parvalbumin GABAergic neurones in the hippocampus Brain Res. 877 2000 262-270
32. O. Nicole et al. Neuroprotection mediated by glial cell line-derived neurotrophic factor: Involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway J. Neurosci. 21 2001 3024-3033
33. D. Perrelet et al. IAPs are essential for GDNF-mediated neuroprotective effects in injured motor neurons in vivo Nat. Cell Biol. 4 2002 175-179
34. H. Sawada et al. Neuroprotective mechanism of glial cell line-derived neurotrophic factor in mesencephalic neurons J. Neurochem. 74 2000 1175-1184
35. G.S. Ralph et al. Identification of potential stroke targets by lentiviral vector mediated overexpression of HIF-1 alpha and HIF-2 alpha in a primary neuronal model of hypoxia J. Cereb. Blood Flow Metab. 24 2004 245-258
36. A.P. Byrnes J.E. Rusby M.J. Wood H.M. Charlton Adenovirus gene transfer causes inflammation in the brain Neuroscience 66 1995 1015-1024
37. C.E. Thomas et al. Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain Mol. Ther. 3 2001 36-46
38. M.M. McMenamin et al. Potential and limitations of a gamma 34.5 mutant of herpes simplex 1 as a gene therapy vector in the CNS Gene Ther. 5 1998 594-604
39. K. Mitrophanous et al. Stable gene transfer to the nervous system using a non-primate lentiviral vector Gene Ther. 6 1999 1808-1818
40. J.B. Rohll et al. Design, production, safety, evaluation, and clinical applications of nonprimate lentiviral vectors Methods Enzymol. 346 2002 466-500
41. E. Martin-Rendon et al. New methods to titrate EIAV-based lentiviral vectors Mol. Ther. 5 2002 566-570